These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28317810)

  • 1. Comparison of cost-effectiveness between the quantiFERON-TB Gold-In-Tube and T-Spot tests for screening health-care workers for latent tuberculosis infection.
    Mukai S; Shigemura K; Yamamichi F; Kitagawa K; Takami N; Nomi M; Arakawa S; Fujisawa M
    Int J Mycobacteriol; 2017; 6(1):83-86. PubMed ID: 28317810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection.
    Venkatappa TK; Punnoose R; Katz DJ; Higgins MP; Banaei N; Graviss EA; Belknap RW; Ho CS
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31462550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.
    Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A
    PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.
    Nijhawan AE; Iroh PA; Brown LS; Winetsky D; Porsa E
    BMC Infect Dis; 2016 Oct; 16(1):564. PubMed ID: 27733123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
    Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
    Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers.
    Tanabe M; Nakamura A; Arai A; Yamasaki D; Hirano K; Kobayashi T; Taguchi O; Kaneko T; Ito M
    Intern Med; 2017; 56(7):773-779. PubMed ID: 28381742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.
    Chien JY; Chiang HT; Lu MC; Ko WC; Yu CJ; Chen YH; Hsueh PR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
    PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.
    Lee JK; Lee HW; Heo EY; Yim JJ; Kim DK
    J Infect Chemother; 2021 Dec; 27(12):1694-1699. PubMed ID: 34412980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Standard E TB-Feron Enzyme-Linked Immunosorbent Assay for Diagnosis of Latent Tuberculosis Infection in Health Care Workers.
    Kweon OJ; Lim YK; Kim HR; Kim TH; Lee MK
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31533984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of Quantiferon-TB Gold in Tube® in screening for latent tuberculosis infection in health workers].
    Martinez-Lacasa X; Font R; Gonzalez S; Sallent S; Jaen A; Lite J; Cuchi E
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):525-31. PubMed ID: 25613557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.
    Pooran A; Booth H; Miller RF; Scott G; Badri M; Huggett JF; Rook G; Zumla A; Dheda K
    BMC Pulm Med; 2010 Feb; 10():7. PubMed ID: 20170555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
    Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-α Antagonist Therapy.
    Jung YJ; Woo HI; Jeon K; Koh WJ; Jang DK; Cha HS; Koh EM; Lee NY; Kang ES
    PLoS One; 2015; 10(10):e0141033. PubMed ID: 26474294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.